SELLAS Life Sciences (SLS) Shares Outstanding (2010 - 2026)

SELLAS Life Sciences (SLS) has 7 years of Shares Outstanding (Entity) data on file, last reported at $261543.0 in Q4 2018.

• On a quarterly basis, Shares Outstanding (Entity) rose 458.77% year-over-year to $261543.0 in Q4 2018; TTM through Dec 2018 was $261543.0, a 458.77% increase from a year earlier, with the FY2018 full-year figure at $261543.0, up 458.77% from the prior year.
• Shares Outstanding (Entity) for Q4 2018 stood at $261543.0, up from $147670.0 in the prior quarter.
• Over the last five years, Shares Outstanding (Entity) for SLS reached as high as $261543.0 in Q4 2018 and fell as low as $3956.0 in Q1 2014.
• Historically, Shares Outstanding (Entity) has averaged $37480.2 across 5 years, with a median of $6083.0 in 2016.
• Across the five-year window, Shares Outstanding (Entity) advanced 2.33% in 2015 and surged 605.03% in 2017, its largest moves.
• Year by year, Shares Outstanding (Entity) stood at $4338.0 in 2014, then climbed by 24.92% to $5419.0 in 2015, then rose by 22.51% to $6639.0 in 2016, then jumped by 605.03% to $46807.0 in 2017, then soared by 458.77% to $261543.0 in 2018.
• Per Business Quant data, the three most recent Shares Outstanding (Entity) figures were $261543.0 in Q4 2018, $147670.0 in Q2 2018, and $123088.0 in Q1 2018.